Viewing Study NCT03994393


Ignite Creation Date: 2025-12-25 @ 1:23 AM
Ignite Modification Date: 2025-12-25 @ 11:36 PM
Study NCT ID: NCT03994393
Status: UNKNOWN
Last Update Posted: 2023-04-21
First Post: 2019-06-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Non Small Cell Lung Cancer Trial of Durvalumab and Tremelimumab in Advanced Epidermal Growth Factor Receptor (EGFR) Mutant Disease.
Sponsor: University of Sydney
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module